LRMR - Larimar Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

LRMR is currently covered by 3 analysts with an average price target of $-4.61. This is a potential upside of $-10.74 (-175.2%) from yesterday's end of day stock price of $6.13.

Larimar Therapeutics's activity chart (see below) currently has 19 price targets and 30 ratings on display. The stock rating distribution of LRMR is 16.67% HOLD and 83.33% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 39.17% with an average time for these price targets to be met of 408.33 days.

Highest price target for LRMR is $25, Lowest price target is $25, average price target is $-4.61.

Most recent stock forecast was given by JONATHAN WOLLEBEN from JMP on 31-May-2024. First documented stock forecast 16-Oct-2015.

Best performing analysts who are covering LRMR - Larimar Therapeutics:

Jason Butler Yatin Suneja Jonathan Wolleben Edward Tenthoff Myles Minter Joseph Schwartz

Currently out of the existing stock ratings of LRMR, 2 are a HOLD (16.67%), 10 are a BUY (83.33%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$25

$18.31 (273.69%)

$25

5 months 21 days ago
(31-May-2024)

1/10 (10%)

$17 (212.50%)

728

Buy

$14

$7.31 (109.27%)

$12

1 years 6 months 4 days ago
(17-May-2023)

2/3 (66.67%)

$10.31 (279.40%)

411

Hold

2 years 2 months 2 days ago
(19-Sep-2022)

0/1 (0%)

$12 (70.59%)

Hold

$5

5 years 2 months 16 days ago
(05-Sep-2019)

1/4 (25%)

$-17.92 (-78.18%)

992

Hold

$8

5 years 2 months 16 days ago
(05-Sep-2019)

2/2 (100%)

$-26.68 (-76.93%)

318

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is LRMR (Larimar Therapeutics) average time for price targets to be met?

On average it took 408.33 days on average for the stock forecasts to be realized with a an average price target met ratio 39.17

Which analyst has the current highest performing score on LRMR (Larimar Therapeutics) with a proven track record?

JASON BUTLER

Which analyst has the current lower performing score on LRMR (Larimar Therapeutics) with a proven track record?

JOSEPH SCHWARTZ

Which analyst has the most public recommendations on LRMR (Larimar Therapeutics)?

Jason Butler works at JMP and has 5 price targets and 3 ratings on LRMR

Which analyst is the currently most bullish on LRMR (Larimar Therapeutics)?

Jonathan Wolleben with highest potential upside - $18.31

Which analyst is the currently most reserved on LRMR (Larimar Therapeutics)?

Edward Tenthoff with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?